Researchers think this represents a potential breakthrough for low- and middle-income countries where access to high-quality imaging evaluations is still limited. 

Improving care for patients with cardiac amyloidosis has emerged as one of the hottest topics in cardiology. Pfizer helped kickstart that trend in 2019 when it gained FDA approval for two separate medications for the rare, but potentially fatal disease. 

Cardiology makes up 10% of the 692 market-cleared clinical AI algorithms in the FDA’s latest update on the number of patient-facing AI now commercialized in the U.S. Experts share their thoughts on how it is being used.

The new healthcare facility is the first of its kind, offering same-day cardiac imaging scans, cardiologist consultations and diagnoses. 

A new 57-page report from MedAxiom explored the latest data on compensation, production, staffing and medical imaging offerings among cardiology programs in the United States. 

"I think everyone would agree that the current fee-for-service model is not working appropriately and there needs to be a fix," regulatory consultant Denise Garris explained in a new interview. 

Juan Carlos Plana Gomez, MD, discussed how cardiology and oncology programs can work together to provide high-quality patient care.

Partho Sengupta, MD, an expert on the use of AI in cardiology, says some of the technologies being developed today will fundamentally change how cardiologists and sonographers do their jobs.